Onkure Therapeutics Inc (OKUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,770 | -29,163 | -16,428 | -7,212 | -19,465 |
| Depreciation Amortization | 252 | 146 | 53 | 10 | 20 |
| Accounts payable and accrued liabilities | 1,780 | 1,816 | -1,164 | -927 | 1,486 |
| Other Working Capital | -2,800 | -1,699 | -3,603 | -1,858 | 514 |
| Other Operating Activity | 2,555 | 938 | 2,852 | 1,398 | -1,091 |
| Operating Cash Flow | $-37,983 | $-27,962 | $-18,290 | $-8,589 | $-18,536 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -23,178 | -31,421 | -26,989 | 0 | 7,400 |
| PPE Investments | -198 | -108 | -31 | -25 | -24 |
| Investing Cash Flow | $-23,376 | $-31,529 | $-27,020 | $-25 | $7,376 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 556 | 407 | N/A | 187 | 87 |
| Other Financing Activity | 131,850 | 131,880 | 132,065 | 46,035 | 47,185 |
| Financing Cash Flow | $132,406 | $132,287 | $132,065 | $46,222 | $47,272 |
| Beginning Cash Position | 53,613 | 53,613 | 53,613 | 53,613 | 17,501 |
| End Cash Position | 124,660 | 126,409 | 140,368 | 91,221 | 53,613 |
| Net Cash Flow | $71,047 | $72,796 | $86,755 | $37,608 | $36,112 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,983 | -27,962 | -18,290 | -8,589 | -18,536 |
| Capital Expenditure | -198 | -108 | -31 | -25 | -24 |
| Free Cash Flow | -38,181 | -28,070 | -18,321 | -8,614 | -18,560 |